1-(2,4-Dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one: A Novel Opioid Receptor Agonist with Less Accompanying Gastrointestinal Dysfunction than Morphine.

Citation data:

Anesthesiology, ISSN: 1528-1175, Vol: 126, Issue: 5, Page: 952-966

Publication Year:
2017
Usage 33
Abstract Views 32
Link-outs 1
Captures 3
Exports-Saves 2
Readers 1
PMID:
28212204
DOI:
10.1097/aln.0000000000001568
Author(s):
Chao, Po-Kuan; Ueng, Shau-Hua; Ou, Li-Chin; Yeh, Teng-Kuang; Chang, Wan-Ting; Chang, Hsiao-Fu; Chen, Shu-Chun; Tao, Pao-Luh; Law, Ping-Yee; Loh, Horace H; Cheng, Ming-Fu; Chuang, Jian-Ying; Chen, Chiung-Tong; Shih, Chuan; Yeh, Shiu-Hwa Show More Hide
Publisher(s):
Ovid Technologies (Wolters Kluwer Health)
Tags:
Medicine
article description
The authors investigated the pharmacology and signaling pathways of the opioid receptors modulated by compound 1, 1-(2,4-dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one.